In-office magnetic resonance imaging to monitor responses to therapy in rheumatoid arthritis
- 66 Downloads
Low-field extremity magnetic resonance imaging (MRI) has been developed as an alternative method for detecting inflammatory changes and structural damage associated with rheumatoid arthritis (RA). Studies have shown that extremity MRI is able to predict future joint damage in patients with early RA and is more sensitive than conventional radiography at detecting joint erosions. This report uses four different cases to illustrate how extremity MRI can be used to monitor disease activity and inform treatment decisions during the management of RA in the routine clinical practice setting.
KeywordsMRI Functional Infliximab Rheumatoid arthritis Rituximab Disease management Drug therapy management
Support for third-party writing assistance for this manuscript, furnished by Neil Anderson, was provided by Genentech, Inc. and Biogen Idec.
- 1.Freeston JE, Conaghan PG, Dass S, Vital E, Hensor EM, Stewart SP et al (2007) Does extremity-MRI improve erosion detection in severely damaged joints? A study of long-standing rheumatoid arthritis using three imaging modalities. Ann Rheum Dis 66:1538–1540. doi: 10.1136/ard.2007.074708 CrossRefPubMedGoogle Scholar
- 7.Gaylis NB, Needell SD, Rudensky D (2007) Comparison of in-office magnetic resonance imaging versus conventional radiography in detecting changes in erosions after one year of infliximab therapy in patients with rheumatoid arthritis. Mod Rheumatol 17:273–278. doi: 10.1007/s10165-007-0591-x CrossRefPubMedGoogle Scholar
- 8.Duer-Jensen A, Vestergaard A, Dohn UM, Ejbjerg B, Hetland ML, Albrecht-Beste E et al (2008) Detection of rheumatoid arthritis bone erosions by two different dedicated extremity MRI units and conventional radiography. Ann Rheum Dis 67:998–1003. doi: 10.1136/ard.2007.076026 CrossRefPubMedGoogle Scholar